Health
First targeted therapy for children with achondroplasia shows persistent height gain – Medical Xpress
Children with achondroplasia, the most common form of disproportionate short stature, grow taller with trends in improved body proportions after two years of daily…
Children with achondroplasia, the most common form of disproportionate short stature, grow taller with trends in improved body proportions after two years of daily vosoritide treatment, a new study analysis finds. Results of the industry-sponsored study will be presented at ENDO 2021, the Endocrine Society’s annual meeting.
“This is the first robust evidence of a precision therapy for achondroplasia,” said the lead investigator, Ravi Savarirayan, M.D., Ph.D., a professor at Murdoch Children’s Research…
-
Noosa News17 hours agoYoung voices shape Sunshine Coast’s future
-
Business17 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News16 hours agoSXSW Sydney Has Announced the First 40 Speakers That’ll Be Taking to the Stage at Its 2025 Conference
-
Business13 hours agoshould I buy hedged or unhedged ASX US-focused ETFs?